Torres Kathryn A., SVP-Payer Contracting & Align., sold 820 shares of the HCA Healthcare, Inc. (NYSE:HCA) in an exchange that happened on November 13th, 2018. The stock was sold at an average price of $142.36 per share, amounting to a transaction worth $116,732. The sale was made public in a document filed with the SEC. Additionally, SVP and Chief Nursing Officer Englebright Jane D. sold 5,081 shares of this stock in a transaction that took place on November 9th, 2018. The stock was sold at an average price of $141.90 per share, for a total exchange amounting to $720,994. After the transaction, the SVP and Chief Nursing Officer Englebright Jane D. currently holds 6,504 shares of the company’s stock, which is worth approximately $924414.
With this stock price’s latest movement, it is now -2.98% away from its 1-year high and 73.16% higher than its 1-year low price. In the past seven days, the stock price volatility for HCA Healthcare, Inc. was 2.69%, whereas its volatility in the past 30 days has been 2.48%. This public company’s stock also has a beta score of 0.51. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
HCA Healthcare, Inc. (NYSE:HCA) most recently published its quarterly earnings results. The firm posted $2.16 earnings per share (EPS) for the three-month period, surpassing analysts’ consensus estimate of $1.90 by $0.26. The publicly-traded organization reported revenue of $11,451.00 million for the quarter, compared to the average analyst forecast calling for $11,289.60 million, which was surpassing the analyst consensus estimate.
Shares of HCA Healthcare, Inc. (HCA) plunged -2.84%, amounting to a loss of -$4.16 per share, to finish the regular trading session at $142.13 on Tuesday 12/04/2018. After beginning the session at $146.1, shares of HCA Healthcare, Inc. reached as high as $147.42 during the day, while hitting a 1-day low of $141.58. Trade volume reached 3,062,267 shares against this stock’s average daily volume of 1.97M shares, with a total float of 271.36M. As a consequence of the price decrease, HCA Healthcare, Inc. now has a current market value of 49.09B.
Kinross Gold Corporation (NYSE:KGC) subtracted -1.06% to its trading price by the close of the most recent session, dropping from its previous closing price of $2.83 to $2.80. This stock increased in value by 8.53% during the last 7-day period, and experienced a gain of 1.82% over the past 30-day period. In the past three months, this stock’s price lost by 0.00%, and subtracted -21.79% to its price during the last six months of trading. KGC demonstrated a yearly price loss of -30.52% , while its year-to-date (YTD) price performance has been down -35.19% . This stock’s price changed by +17.65% compared to its 90-day low, and moved down -9.39% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the KGC stock as “Hold”. In the short-term, Kinross Gold Corporation (KGC) has a 20-day average volume of 14,688,425 shares and short-term indicators sets the KGC stock as “ 40% Buy ” on average basis. In the medium-term, KGC stock has a 50-Day average volume of 14,573,700 shares and medium-term indicators gave the average rating of “ 25% Buy ”, while in the long-term period the FB stock has a 100-Day average volume of 11,358,205 shares. On average, long-term indicators rated the stock as “67% Sell ”. The overall picture from all short, medium and long-term indicators sets the KGC stock as “8% Buy ” on average basis.
Recently, multiple brokerages have sent out reports on KGC. RBC Capital Mkts, for example, Downgrade its rating on shares of Kinross Gold Corporation from “Outperform ” to a “ Sector Perform”according to a research note from Monday August 20th, 2018. while giving the stock a “ Outperform” from “Neutral ” rating, as stated in a research report from Friday, November 10th, 2017. Citigroup, on the other hand, Upgrade a from “Sell ” to “ Neutral” rating on this stock in a research note dated Friday, September 1st, 2017.
In other news related to Kinross Gold Corporation stock, 94.34% shares of KGC held by institutions. The total number of institutions who held the KGC shares was 381, according to most recent SEC filling. During the past quarter, total 56,454,848 shares held by institutions with the net change of -65,958 shares. In the meantime, 54 new institutions bought the shares of Kinross Gold Corporation for the first time and 49 institutions sold all their holdings in the company’s common stock. 159 institutions increased their investment in the KGC stock and 169 institutions decreased their investment in the Kinross Gold Corporation (KGC)’s stock during the last quarter.